Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating activities    
Net Income (loss) - including non-controlling interest $ (571,972) $ 2,752,141
Adjustments to reconcile net income (loss) to net cash (used) provided by operations    
Amortization of debt discount 11,933 10,305
Amortization of expense on note receivable (3,309) (28,530)
Depreciation expense 80
Amortization of website development costs 1,336
Impairment of an investment   195,000
Net loss from equity method investment 43,812 14,278
Unrealized (gain) on available - for - sale securities 304,524 (3,069,500)
Bad debt on note receivable 141,000
Gain on disposal of non-controlling investment (83,064)
Gain on deconsolidation of subsidiary (Krypto Ventures, Inc.) (153,907)
Gain on forgiveness of PPP loan (34,500)
Changes in operating assets and liabilities    
Prepaids 25,000
Increase (decrease) in    
Accounts payable and accrued expenses 147,058 93,716
Accounts payable and accrued expenses - related party 60,000 90,000
Accumulated losses on unconsolidated investees in excess of investment 1,226 58,478
Net cash from (used in) operating activities 51,208 (61,883)
Investing activities    
Notes receivable (119,000)
Interest receivable (9,026) (7,890)
Website development cost (9,500)
Advance to a related party (5,142)
Cash disposed in deconsolidation of subsidiary (53,178)
Net cash used in investing activities (9,026) (194,710)
Financing activities    
Payment of convertible note payable
Payment of from issuance of note payable (25,000)
Proceeds from issuance of note payable, related party 25,000
Proceeds from issuance of convertible note payable, related party, net 50,000
Proceeds from short term advances, related parties 407,500
Net cash provided by financing activities 457,500
Net increase in cash 42,182 216,687
Cash and cash equivalents - beginning of period 227,558 5,632
Cash and cash equivalents - end of period 269,740 222,319
Supplemental disclosure of cash flow information    
Cash paid for interest 27,218 27,782
Cash paid for income tax
Supplemental disclosure of non-cash investing and financing activities    
Investment at fair value received from issuance of note receivable 43,000
Beneficial conversion features on convertible notes payable - related party $ 3,799